Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol
The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 4/20 | 0.39 |
| ▸ | SLC6A2 known ✓ | P23975 | 12/20 | 0.39 |
| ▸ | SLC6A4 known ✓ | P31645 | 11/20 | 0.39 |
| ▸ | SLC6A3 known ✓ | Q01959 | 4/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL6782504 | 1.00 | HRH1 (0.39) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| Maleic Acid SCHEMBL6782497 | 1.00 | HRH1 (0.39) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| SCHEMBL6791319 | 0.87 | HRH1 (0.42) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| SCHEMBL6791321 | 0.87 | HRH1 (0.42) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| SCHEMBL6790774 | 0.83 | BRD4 (0.40) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| SCHEMBL6790777 | 0.83 | BRD4 (0.40) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| Maleic Acid SCHEMBL6790540 | 0.82 | SLC6A2 (0.41) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| Maleic Acid SCHEMBL6790541 | 0.82 | SLC6A2 (0.41) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| Fumaric Acid SCHEMBL6790544 | 0.82 | SLC6A2 (0.41) | HRH1SLC6A2SLC6A4CHRM3LMNA | |
| SCHEMBL6784584 | 0.81 | SLC6A2 (0.36) | SLC6A2SLC6A4CHRM3LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6828314-B2 | Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity | PFIZER | 2004-12-07 | — | — | US | disclosed |
| US-20030225058-A1 | Substituted azepino[4,5b]indoline derivatives | PHARMACIA & UPJOHN COMPANY | 2003-12-04 | — | — | US | disclosed |
| US-6586421-B2 | For therapy of central nervous system, including diseases, disorders, and conditions related to, such as anxiety, depression, hypertension, migraine, obesity, compulsive disorders, schizophrenia, autism, neurodegenerative disorders | PHARMACIA & UPJOHN COMPANY | 2003-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225058-A1 | Substituted azepino[4,5b]indoline derivatives | HTR5A, HTR1A, HTR4 | HRH1 190/4885SLC6A2 104/4885SLC6A4 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.